Predictors of HbA1c levels in patients initiating metformin

References

• Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach, update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-9
   PubMed Web of Science ®Google Scholar
• Cook MN, Girman CJ, Stein PP, Alexander CM. Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with type 2 diabetes in UK primary care. Diabet Med 2007;24:350-8
   PubMed Web of Science ®Google Scholar
• Thomsen RW, Baggesen LM, Svensson E, et al. Early glycaemic control among patients with type 2 diabetes and initial glucose-lowering treatment: a 13-year population-based cohort study. Diabetes Obes Metab 2015;17:771-80
   PubMed Web of Science ®Google Scholar
• Martono DP, Lub R, Heerspink HJL, et al. Predictors of response in initial users of metformin and sulphonylurea derivatives: a systematic review. Diabet Med 2015;32:854-64
   Web of Science ®Google Scholar
• Donnelly LA, Doney ASF, Hattersley AT, et al. The effect of obesity on glycaemic response to metformin or sulphonylureas in Type 2 diabetes. Diabet Med 2006;23:128-33
   PubMed Web of Science ®Google Scholar
• Nichols GA, Conner C, Brown JB. Initial nonadherence, primary failure and therapeutic success of metformin monotherapy in clinical practice. Curr Med Res Opin 2010;26:2127-35
   PubMed Web of Science ®Google Scholar
• Bauer S, Nauck MA. Polypharmacy in people with type 1 and type 2 diabetes is justified by current guidelines – a comprehensive assessment of drug prescriptions in patients needing inpatient treatment for diabetes-associated problems. Diabet Med 2014;31:1078-85
   PubMed Web of Science ®Google Scholar
• Struijs JN, Baan CA, Schellevis FG, et al. Comorbidity in patients with diabetes mellitus: impact on medical health care utilization. BMC Health Serv Res 2006;6:84
   PubMed Web of Science ®Google Scholar
• Wami WM, Buntinx F, Bartholomeeusen S, et al. Influence of chronic comorbidity and medication on the efficacy of treatment in patients with diabetes in general practice. Br J Gen Pract 2013;63:e267-73
   PubMed Web of Science ®Google Scholar
• Vitry AI, Roughead EE, Preiss AK, et al. Influence of comorbidities on therapeutic progression of diabetes treatment in Australian veterans: a cohort study. PLoS One 2010;5:e14024
   PubMed Web of Science ®Google Scholar
• Caughey GE, Roughead EE, Vitry AI, et al. Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts. Diabetes Res Clin Pract 2010;87:385-93
   PubMed Web of Science ®Google Scholar
• Voorham J, Haaijer-Ruskamp FM, Wolffenbuttel BH, et al. Differential effects of comorbidity on antihypertensive and glucose-regulating treatment in diabetes mellitus – a cohort study. PLoS One 2012;7:e38707
   PubMed Web of Science ®Google Scholar
• Voorham J, Denig P. Computerized extraction of information on the quality of diabetes care from free text in electronic patient records of general practitioners. J Am Med Informatics Assoc 2007;14:349-54
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, Greene T. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461-70
   PubMed Web of Science ®Google Scholar
• Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol 2006;59:1087-91
   PubMed Web of Science ®Google Scholar
• White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011;30:377-99
   PubMed Web of Science ®Google Scholar
• Wood AM, White IR, Royston P. How should variable selection be performed with multiply imputed data? Stat Med 2008;27:3227-46
   PubMed Web of Science ®Google Scholar
• Walraven I, Mast MR, Hoekstra T, et al. Distinct HbA1c trajectories in a type 2 diabetes cohort. Acta Diabetol 2015;52:267-75
   PubMed Web of Science ®Google Scholar
• Sidorenkov G, Haaijer-Ruskamp FM, de Zeeuw D, et al. A longitudinal study examining adherence to guidelines in diabetes care according to different definitions of adequacy and timeliness. PLoS One 2011;6:e24278
   PubMed Web of Science ®Google Scholar
• Rutten GEHM, De Grauw WJC, Nijpels G, et al. NHG-Standaard Diabetes mellitus type 2 (derde herziening) [in Dutch]. Huisarts Wet 2013;56:512-25
   Google Scholar
• Preiss D, Sattar N. Does the LDL receptor play a role in the risk of developing type 2 diabetes? JAMA 2015;313:1016-17
   PubMed Web of Science ®Google Scholar
• Preiss D, Seshasai SR,Welsh P, et al. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy. JAMA 2011;305:2556-64
   PubMed Web of Science ®Google Scholar
• Swerdlow DI, Preiss D, Kuchenbaecker KB, et al. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight. Lancet 2015;385:351-61
   PubMed Web of Science ®Google Scholar
• Mishra GD, Dobson AJ. Multiple imputation for body mass index: lessons from the Australian Longitudinal Study on Women’s Health. Stat Med 2004;23:3077-87
   PubMed Web of Science ®Google Scholar
• Nichols GA, Alexander CM, Girman CJ, et al. Treatment escalation and rise in HbA1c following successful initial metformin therapy. Diabetes Care 2006;29:504-9
   PubMed Web of Science ®Google Scholar
• Grant R, Adams AS, Trinacty CM, et al. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care 2007;30:807-12
   PubMed Web of Science ®Google Scholar
• Nau DP. Recommendations for improving adherence to type 2 diabetes mellitus therapy – focus on optimizing oral and non-insulin therapies. Am J Manag Care 2012;18:S49-S54
   PubMedGoogle Scholar
• Stone MA, Charpentier G, Doggen K, et al. Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study. Diabetes Care 2013;36:2628-38
   PubMed Web of Science ®Google Scholar
• Jablonski K, McAteer J, Bakker P, et al. Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the Diabetes Prevention Program. Diabetes 2010;59:2672-81
   PubMed Web of Science ®Google Scholar
• Goswami S, Yee S, Stocker S, et al. Genetic variants in transcription factors are associated with the pharmacokinetics and pharmacodynamics of metformin. Clin Pharmacol Ther 2014;96:370-9
   PubMed Web of Science ®Google Scholar